RVNC: Revance (RVNC) and Teoxane reached a settlement under which Teoxane will be the exclusive distributor for Revance’s Daxxify, in Australia and New Zealand. With this, Revance extended the deadline for Crown’s tender offer to buy all of Revance’s outstanding shares to November 1, 2024.
ICCH: ICC Holdings (ICCH) filed a definitive proxy statement. The special meeting of shareholders will be held on November 26, 2024.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok